Atlas Trials

NSCLC Patients With EGFR Activating Mutation

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch NSCLC Patients With EGFR Activating Mutation

RecordFirmDate
First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor (NCT07755397)Jubilant Therapeutics India Limited2024-08-26
A Multicenter Randomized Phase III Study Comparing Second-line Treatment With Chemotherapy Associated or Not to Erlotinib in NSCLC Patients With Secondary Resistance to TKI-EGFR (NCT02178397)Centre Francois Baclesse2014-06-01

Track NSCLC Patients With EGFR Activating Mutation automatically

Every clearance here is in the API, with alerts when new ones post.